These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22483234)

  • 61. Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.
    Wari MN; Vallonthaiel AG; Ahmed A; Saxena D; Iyer VK; Mathur SR; Agarwala S; Bakhshi S; Srinivas V; Chattopadhyaya P; Sharma A; Gupta SD; Dinda A
    Pediatr Surg Int; 2017 Jun; 33(6):695-703. PubMed ID: 28432433
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.
    Huang J; Soffer SZ; Kim ES; Yokoi A; Moore JT; McCrudden KW; Manley C; Middlesworth W; O'Toole K; Stolar C; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2002 Mar; 37(3):523-7. PubMed ID: 11877681
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology.
    Peres EM; Savasan S; Cushing B; Abella S; Mohamed AN
    Cancer Genet Cytogenet; 2004 Jan; 148(1):66-70. PubMed ID: 14697643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor.
    Sredni ST; de Camargo B; Lopes LF; Teixeira R; Simpson A
    Med Pediatr Oncol; 2001 Nov; 37(5):455-8. PubMed ID: 11745874
    [TBL] [Abstract][Full Text] [Related]  

  • 65.
    Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple mechanisms of MYCN dysregulation in Wilms tumour.
    Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
    Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children.
    Wang J; Lou S; Huang X; Mo Y; Wang Z; Zhu J; Tian X; Shi J; Zhou H; He J; Ruan J
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32083300
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor.
    Yi Y; Polosukhina D; Love HD; Hembd A; Pickup M; Moses HL; Lovvorn HN; Zent R; Clark PE
    J Urol; 2015 Dec; 194(6):1762-70. PubMed ID: 25934441
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.
    Blish KR; Clausen KA; Hawkins GA; Garvin AJ; Willingham MC; Turner JC; Torti FM; Torti SV
    J Exp Clin Cancer Res; 2010 Nov; 29(1):147. PubMed ID: 21080955
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of YY1 in Wilms tumors with favorable histology is a risk factor for adverse outcomes.
    Zapata-Tarres M; Juarez-Villegas LE; Maldonado-Valenzuela A; Baay-Guzman GJ; Lopez-Perez TV; Cabrera-Muñoz L; Sadowinski-Pine S; Huerta-Yepez S
    Future Oncol; 2019 Apr; 15(11):1231-1241. PubMed ID: 30810052
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peptide spectra in Wilms tumor that associate with adverse outcomes.
    Murphy AJ; Pierce J; Seeley EH; Sullivan LM; Ruchelli ED; Nance ML; Caprioli RM; Lovvorn HN
    J Surg Res; 2015 Jun; 196(2):332-8. PubMed ID: 25868780
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The epithelial mesenchymal transition process in wilms tumor: a study based on a xenograft model.
    Giner F; Machado I; Noguera R; Villamon E; Pellin A; Calabuig-Fariñas S; Peydro-Olaya A; Navarro S; Llombart-Bosch A
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):369-75. PubMed ID: 21285869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
    Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
    J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.
    Breslow NE; Beckwith JB; Perlman EJ; Reeve AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):260-7. PubMed ID: 16700047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage.
    Uno K; Rastegar B; Jansson C; Durand G; Valind A; Chattopadhyay S; Bertolotti A; Ciceri S; Spreafico F; Collini P; Perotti D; Mengelbier LH; Gisselsson D
    Mod Pathol; 2024 Jan; 37(1):100382. PubMed ID: 37951357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis.
    Morgan ED; Yahaya JJ; Ngaiza AI; Othieno E; Livex OA
    J Egypt Natl Canc Inst; 2023 Jul; 35(1):23. PubMed ID: 37518096
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis.
    Lizhi L; Rongdong H; Shaohua H; Yingquan K; Huihuang X; Shan L; Kunbin T; Di X
    Fetal Pediatr Pathol; 2021 Dec; 40(6):653-662. PubMed ID: 32066305
    [No Abstract]   [Full Text] [Related]  

  • 78. Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis.
    He Y; Cui X; Lin Y; Wang Y; Wu D; Fang Y
    Biomed Res Int; 2021; 2021():8826286. PubMed ID: 33628817
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.
    Armstrong AE; Gadd S; Huff V; Gerhard DS; Dome JS; Perlman EJ
    PLoS One; 2018; 13(12):e0208936. PubMed ID: 30543698
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glypican-3 expression in Wilms tumor and hepatoblastoma.
    Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
    J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.